|
⚲
|
| Keyboard |
| Pivotal bioVenture Partners Fund I UGP Ltd
✚
|
|
|---|---|
| CIK # | 0001752847 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Vaxcyte Inc | 79.8 | ||
| Oculis Holding AG | 44.7 | ||
| Evommune Inc | 44.3 | ||
| Arcutis Biotherapeutics Inc | 31.9 | ||
| Trevi Therapeutics Inc | 18.5 | ||
| Immunome Inc | 16.0 | ||
| Maplight Therapeutics Inc | 12.4 | ||
| Zenas Biopharma Inc | 11.6 | ||
| Bioage Labs Inc | 11.4 | ||
| Cerecor Inc | 4.4 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001752847] | |
| 3 | [0001752847] | |
| 4 | [0001752847] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Evommune Inc EVMN
Series Seed Preferred Stock · derivative
|
2025-11-07 | Conversion | 3,572,816 | ||
|
Evommune Inc EVMN
Series Seed Preferred Stock · derivative
|
2025-11-07 | Conversion | 7,145,647 | ||
|
Evommune Inc EVMN
Series C Preferred Stock · derivative
|
2025-11-07 | Conversion | 313,571 | ||
|
Evommune Inc EVMN
Series C Preferred Stock · derivative
|
2025-11-07 | Conversion | 313,571 | ||
|
Evommune Inc EVMN
Series C Preferred Stock · derivative
|
2025-11-07 | Conversion | 2,508,575 | ||
|
Evommune Inc EVMN
Common Stock
|
2025-11-07 | Conversion | 1,632,441 | ||
|
Evommune Inc EVMN
Common Stock
|
2025-11-07 | Conversion | 1,441,032 | ||
|
Evommune Inc EVMN
Common Stock
|
2025-11-07 | Conversion | 294,502 | ||
|
Evommune Inc EVMN
Series B Preferred Stock · derivative
|
2025-11-07 | Conversion | 2,104,740 | ||
|
Evommune Inc EVMN
Series B Preferred Stock · derivative
|
2025-11-07 | Conversion | 1,895,260 | ||
|
Evommune Inc EVMN
Series A Preferred Stock · derivative
|
2025-11-07 | Conversion | 7,230,283 | ||
|
Evommune Inc EVMN
Series A Preferred Stock · derivative
|
2025-11-07 | Conversion | 2,582,243 | ||
|
Inozyme Pharma Inc INZY
Common Stock
|
2023-08-01 | Buy | 714,285 | $4.80 | 3,428,568 |
|
Inozyme Pharma Inc INZY
Common Stock
|
2023-08-01 | Buy | 119,048 | $4.80 | 571,430 |
|
Inozyme Pharma Inc INZY
Common Stock
|
2022-04-19 | Buy | 1,070,000 | $3.69 | 3,948,300 |
|
Inozyme Pharma Inc INZY
Common Stock
|
2020-07-28 | Conversion | 1,403,654 | ||
|
Inozyme Pharma Inc INZY
Common Stock
|
2020-07-28 | Buy | 187,500 | $16.00 | 3,000,000 |
|
Inozyme Pharma Inc INZY
Series A-2 Convertible Preferred Stock · derivative
|
2020-07-28 | Conversion | 10,489,510 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Series B-1 Tranche A Convertible Preferred Stock · derivative
|
2018-09-28 | Conversion | 7,446,904 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Series B-1 Tranche B Convertible Preferred Stock · derivative
|
2018-09-28 | Conversion | 9,502,249 | $0.00 | |
| showing 20 of 23 most recent transactions | |||||